Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Connecticut for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Connecticut only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Connecticut (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jerry Tsong (NPI 1760412787)

Field	Value
Entity Type	Individual
Organization	Jerry Tsong
Address	4 Dearfield Dr
City	Greenwich
State	CT
ZIP	06831
Taxonomy	Ophthalmology Physician
NPI Enumerated	July 4, 2006

Payer Source	Total Paid
Medicare	$1.9M
Medicaid	$0

Key Findings

This provider is effectively single-payer: total Medicare revenue is $1.9M and there is no Medicaid billing on file, so Medicare is the sole reported public-payer revenue stream for this NPI. The absence of Medicaid billing suggests analyses of payer mix or state-Medicaid network strategies are not applicable for this provider.

Revenue is highly concentrated in a small set of services: the precomputed top 3 Medicare codes account for 58.9% of this provider's Medicare revenue. Those top codes are J0178 (27.0% of Medicare revenue), J2777 (20.3%), and 92014 (11.7%), so any changes to reimbursement or utilization for these three codes would materially affect the provider's topline.

The code mix indicates a retina-focused ophthalmology practice with high procedural and diagnostic intensity: large shares come from intravitreal drug administration (J0178, J2777, J2778) and associated procedure codes like 67028, while office-based retinal follow-up and imaging codes (92014, 92250, 92134) also contribute meaningfully. This combination of high-volume injections plus imaging and comprehensive exams is consistent with chronic retinal disease management (e.g., AMD or diabetic macular edema) rather than a general ophthalmology-only practice.

Clinical visit volume for established patients is anomalously high: 92014 (established comprehensive exam) accounts for $215.9K (11.7%) of Medicare revenue and ranks #163 of 35415 providers nationally (100th percentile, labeled an "extreme outlier, far above typical national volume"). Alongside 92012 (also labeled an "extreme outlier"), these ranks indicate follow-up and exam throughput that is far above typical peer levels and likely reflects a high revisit cadence tied to ongoing treatment regimens.

Imaging and diagnostic services are another notable strength: 92250 (fundus photography) generated $59.8K and ranks #34 of 25087 providers nationally (100th percentile, "extreme outlier"), and 92134 (retinal OCT) contributed $42.9K and sits at the 93rd percentile. These standings show the provider is a heavy user of retinal imaging relative to national peers, supporting the characterization of a practice built around ongoing retinal disease monitoring.

By contrast, the major intravitreal drug codes do not show national dominance: J0178 (aflibercept) ranks #1604 of 3204 (50th percentile, "typical, unremarkable volume"), J2777 (faricimab) ranks #808 of 2039 (60th percentile), and J2778 (ranibizumab) ranks #413 of 1208 (66th percentile). Those percentiles imply the provider administers these drugs at typical national volumes for injection-focused retinal specialists rather than as a top national outlier in drug administration.

There is a material, somewhat atypical revenue contribution from J3490 (unclassified drugs): 87 claims with $1839 avg paid/claim produced $160K (8.6% of Medicare revenue) and ranks #915 of 2838 providers (67th percentile). The large average payment per claim and sizable share of revenue from J3490 suggest that unclassified or variable drug billing is a meaningful element of the practice's Medicare revenue profile and merits closer review in revenue-line analyses.

This provider has long tenure in Medicare: the NPI was enumerated on 2006-07-04 (~20 years ago), indicating an established billing history and operational stability. Given the mix of high-volume follow-up exams and heavy imaging use combined with steady injection volumes, the practice appears operationally mature with entrenched clinical workflows focused on retinal disease management.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	720	$690	$499.7K
J2777	Injection, faricimab‑svoa, 0.1 mg	12,960	$30	$375.9K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,270	$100	$215.9K
J2778	Injection, ranibizumab, 0.1 mg	1,070	$180	$190.6K
J3490	Unclassified drugs	90	$1,840	$160K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,110	$100	$105.8K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	1,290	$70	$93.8K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	1,990	$30	$59.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,260	$30	$42.9K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	350	$120	$41.5K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Connecticut Distribution

Jerry Tsong — 4 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Connecticut

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	25	40	830	$690	$713.1K
J2777	9	30	8,190	$30	$340.4K
J2778	4	20	410	$180	$117.8K
J3490	3	20	50	$1,380	$76K
67028	10	50	540	$100	$66.4K
J2781	9	10	440	$120	$55.7K
92014	1	580	100	$90	$18.6K
92012	4	300	120	$70	$15.2K
92235	8	30	40	$110	$14.8K
99214	4,455	6,480	90	$90	$14.2K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jerry Tsong, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Refocus Eye Health Of Central Connecticut, P.C.	CT	Ophthalmology Physician	$0	$8.2M
David Tom	CT	Ophthalmology Physician	$2.5M	$0
John Huang	CT	Ophthalmology Physician	$2M	$0
Erol Verter	CT	Ophthalmology Physician	$1.7M	$0
Gregory Haffner	CT	Ophthalmology Physician	$1.4M	$0
Neil Kalbag	CT	Ophthalmology Physician	$1.1M	$0
Rebecca Shields	NY	Ophthalmology Physician	$319.3K	$331.6K
Neal Adams	MD	Ophthalmology Physician	$497.9K	$5.3K
Susel Oropesa	CT	Ophthalmology Physician	$405.3K	$0
Suresh Mandava	CT	Ophthalmology Physician	$354.2K	$0

Nearby Providers

Other providers in the same ZIP code as Jerry Tsong, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Orthopaedic & Neurosurgery Specialists, PLLC	CT	Orthopaedic Surgery Physician	$0	$1.1M
Tamar Kessel	CT	Physical Medicine & Rehabilitation Physician	$540.4K	$0
Aleksandr Levchenko	CT	Physical Medicine & Rehabilitation Physician	$339.9K	$0
Seth Miller	CT	Orthopaedic Surgery Physician	$303.3K	$0
Jonathan Berliner	CT	Orthopaedic Surgery Physician	$281.2K	$0
Kevin Choo	CT	Orthopaedic Surgery Physician	$274.6K	$0
Jeffrey Heftler	CT	Physical Medicine & Rehabilitation Physician	$268.1K	$0
Donna Densel	CT	Ophthalmology Physician	$247.7K	$0
Francis Ennis	CT	Orthopaedic Surgery Physician	$239.4K	$0
Mark Vitale	CT	Orthopaedic Hand Surgery Physician	$227.9K	$0

Jerry Tsong — Billing Profile & Reimbursement Data

Sign up for Jerry Tsong — Billing Profile & Reimbursement Data policy alerts

Jerry Tsong — Billing Profile & Reimbursement Data

Sign up for Jerry Tsong — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References